Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 180 M191 M178 M206 M 755 M Research & development ———— — Operating income 333 M290 M310 M401 M 1.33 B Non-Operating Income, Total -1 M17 M19 M1 M 36 M Interest expense, net of interest capitalized 8 M8 M11 M8 M 35 M Non-Operating Income, excl. Interest Expenses -3 M17 M19 M0 33 M Unusual income/expense 2 M001 M — Pretax income 323 M299 M318 M394 M 1.33 B Equity in earnings -2 M4 M4 M16 M 22 M Taxes 72 M64 M71 M78 M 285 M Non-controlling/minority interest 4 M1 M4 M3 M 12 M After tax other income/expense ———— — Net income before discontinued operations 246 M238 M248 M327 M 1.06 B Discontinued operations 0000 — Net income 246 M238 M248 M327 M 1.06 B Dilution adjustment 0000 0 Preferred dividends 46 M7 M5 M21 M 79 M Diluted net income available to common stockholders 200 M231 M243 M306 M 980 M Basic earnings per share (Basic EPS) 0.630.610.630.84 2.71 Diluted earnings per share (Diluted EPS) 0.620.60.630.83 2.68 Average basic shares outstanding 393.29 M393.55 M393.11 M392.04 M — Diluted shares outstanding 394.67 M395.77 M394.59 M392.7 M — EBITDA 594 M564 M561 M688 M 2.41 B EBIT 511 M479 M479 M603 M 2.07 B Cost of revenue 3.29 B3.22 B3.27 B3.62 B 13.4 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 83 M85 M82 M85 M 335 M